Research Projects

Species Identification of Non-Tuberculous Mycobacteria in the Ugandan Population

Kampala, Uganda
June 2019 – ongoing

Infections with non-tuberculous mycobacteria (NTM) are on the rise worldwide, directing the global focus to these lesser known organisms. NTM range from harmless microbes to...

The ALPHA Study

Kampala, Uganda
August 2019 – ongoing

Amikacin Exposure and Toxicity – Pharmacokinetic Pharmacodynamic Analysis in Patients with Multidrug-Resistant Tuberculosis in Uganda : A Pilot Study Treatment of patients with multidrug-resistant TB...

Sexually transmitted infections

Kampala, Uganda
October 1, 2017 – April 1, 2019

Strengthening capacity to optimally care for vulnerable groups at risk for sexually transmitted infections in Kampala, Uganda. Sexually transmitted infections (STIs) are among the most...

Gestational diabetes mellitus in HIV-infected women

Kampala, Uganda
February 1 2019 – ongoing

Diabetes mellitus (DM) is one of the most common non-communicable diseases worldwide. The number of people with diabetes is increasing rapidly, especially in sub-Saharan Africa....

Antimicrobial resistance in urinary tract infections

Kampala, Uganda
March 1, 2017 – June 30, 2019

A cross-sectional study was conducted as part of routine surveillance at an outpatient HIV-clinic in Kampala, Uganda. In total, 200 patients aged 18 years and...

Intensive pharmacokinetics (IPK)

Kampala, Uganda
February 1 2017 – October 1 2018

In addition to the recently completed SOUTH study (see also “past projects”), tuberculosis/HIV co-infected adults were prospectively enrolled into this study in which serum concentrations...

RHINOS follow-up study (RHINUP)

Kampala, Uganda
January 1 2017 – January 1 2018

This follow-up study on patients identified with HIV drug resistance in 2015 was recently completed. HIV-infected adults that previously participated in the RHINOS study (see...

Resistance in HIV-infected individuals in North and South (RHINOS)

Kampala, Uganda
June 4 – September 30 2015

In 2015, this study enrolled over 2700 HIV-infected Ugandan adults within 4 months. The majority of patients had been on antiretroviral treatment (ART) for more...

Study on outcomes related to Tuberculosis and HIV drug concentrations in Uganda (SOUTH)

Kampala, Uganda
April 1 2013 – today

This currently ongoing research study investigates the association between anti-TB drug concentrations and TB treatment outcome in TB/HIV co-infected Ugandan adults. Serum concentrations of all...

Associated